Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (S) Rivastigmine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116334022B reveals high-efficiency transaminase mutant for Rivastigmine intermediate. Offers superior yield and purity for scalable pharmaceutical manufacturing.
Novel three-step asymmetric synthesis route for high-purity (S)-rivastigmine intermediates offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103319374A details a high-yield asymmetric route for (S)-rivastigmine using Ellman auxiliary, offering significant cost reduction in pharmaceutical intermediate manufacturing.